![\"\"](\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2022\/01\/Barritt-headshot-300x245.jpeg\")
<\/p>\n<\/p>\n
<\/p>\n
Sidney Barritt IV, MD, MSCR, is a tenured associate professor at the University of North Carolina. He is the Director of Hepatology in the UNC liver center and the Transplant Hepatology Fellowship Program Director. Dr. Barritt conducts clinical outcomes research in nonalcoholic fatty liver disease (NAFLD), general hepatology, and liver transplantation.\u00a0 Dr. Barritt leads the UNC Liver Center\u2019s clinical trial program in NAFLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials and is also a member of the NIH sponsored Drug Induced Liver Injury Network and the PCORI PAL-Liver study.\u00a0 Dr. Barritt is also a founding PI for an international registry of patients with liver disease and SARS-CoV2 infection called SECURE-Liver.\u00a0 Dr. Barritt is a collaborator and advisor to multiple other investigators in the allied schools of health, including the Gillings School of Global Public Health, the Eshelman School of Pharmacy, and the UNC Adams School of Dentistry.\u00a0 Dr. Barritt is a Fellow of the American Association for the Study of Liver Disease and the American College of Gastroenterology.\u00a0 Outside of work, Dr. Barritt enjoys spending time with his family, road running, and triathlons.<\/p>\n","protected":false},"excerpt":{"rendered":"